Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07643493
PHASE4

CleaRRAflow: Isotonic Solution vs. TPA for IVH Clearance

Sponsor: David Dornbos

View on ClinicalTrials.gov

Summary

The study aims to investigate the effect of continuous tPA irrigation into the ventricles. Investigators believe it may be superior to the traditional every 8-hour bolus dosing and continuous isotonic solution irrigation alone. The protocol plans to analyze blood clearance and functional outcomes in the patients.

Official title: Utility of Continuous Intrathecal TPA Infusion for IVH Clearance With Ventricular Irrigation

Key Details

Gender

All

Age Range

18 Years - 99 Years

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2026-06-01

Completion Date

2029-05-31

Last Updated

2026-06-11

Healthy Volunteers

No

Interventions

DRUG

Tissue Plasminogen Activator (tPA)

Tissue Plasminogen Activator (tPA) is infused through the ClearRRAflow catheter into the ventricular system to promote clearance of intraventricular hemorrhage.

PROCEDURE

Isotonic solution

Isotonic solution irrigation delivered through the CleaRRAflow catheter into the ventricular system to promote intraventricular hemorrhage clearance.

Locations (1)

UKHC

Lexington, Kentucky, United States